Board of Directors


Jethro Holter

Jethro Holter has over 20 years of international experience in the life science and diagnostic industry. He was recently the Group CEO of ArcticZymes Technologies ASA (former Biotec Pharmacon ASA), and CEO of its subsidiaries, ArcticZymes AS and Biotec BetaGlucans AS, respectively. Jethro has previous experience from Life Technologies (Thermo Fisher Scientific) in international business development of B2B/OEM solutions with Diagnostic and Life Science companies as well as other commercial experience. Earlier in his career, he was R&D Director at Mole Genetics AS and started his industrial career as a molecular biology researcher at Pfizer. Jethro holds a Ph.D in Molecular Neuroscience from Cardiff University, UK.

Board Member

Camilla Huse Bondesson

Camilla holds an Executive MBA from Stockholm University and is currently Chairman of the Board of Immuneed AB and TdB Labs AB. Camilla has over 30 years of international operational and strategic experience from leading positions in companies in the biotechnology field, including as head of Behring Diagnostica AB, international product manager for Biacore, marketing manager for Amersham Biosciences (now Cytiva) and VP Marketing for Gyros AB.

Since 2004, Camilla has worked as a consultant and partner at Conlega, a consulting company focusing on Life Science.

Board Member

Thorvald Steen

Thorvald Steen was educated from Royal Norwegian Naval Academy in 1984. He left the Navy in 1990 and was employed by Norsk Hydro, Oil & Gas, which he left in 1999.  For 20 years, he held various roles in the financial industry, both as a general manager and as a senior corporate advisor. The past four years Thorvald has been a private investor, board member and adviser, and holds positions as chairman and board member across diverse businesses.

Board Member

Marie Buchmann

Marie holds a medical degree and a Ph.D from the University of Oslo. She is an approved specialist in both clinical chemistry and clinical pharmacology. She has a long career in various positions as medical advisor and medical director in both the pharma  and diagnostic industry. She was the medical director at Fürst Medisinske Laboratorium in the period 2000-2022.

Board Member

Richard Kurtz

Richard is the Vice President of Corporate Business Development for Bio-Rad Laboratories, a life science research and clinical diagnostics company that has been serving customers worldwide since 1952. In his current role, Richard executes corporate strategies to deliver long-term company growth, focusing on acquisitions, strategic investments and corporate partnerships in both Life Science and Clinical Diagnostics.

Richard has over 20 years of industry experience. Previously, Richard was the Marketing Director for the Life Science Gene Expression Division, a role in which he managed product-line strategies, product development and global commercialization activities for one of Bio-Rad’s largest Life Science product portfolios. He has extensive experience in strategic business planning, technology assessment, product development and commercialization. Richard received his Ph.D in Molecular Biology from Northwestern University prior to transitioning into industry.

Board Member

Rune Sørum

Rune holds a Master of Science in Business and Economics (siviløkonom) from Copenhagen School of Economics and Business Administration. He is a Norwegian citizen with residence in Oslo, Norway. Rune is currently a Partner in Televenture Management.

Before joining Televenture, Rune was a private investor and a senior adviser for European companies working in both Asia and the Middle East.
Rune has held several board positions in Norwegian investment companies.